Core business


Acobiom’s business model is based on two main activities:

(1) developing and commercializing diagnostics and companion diagnostics (CDx), notably for personalized medicine applications;

(2) providing services in the fields (+)



Acobiom was founded by Didier Ritter and Dr David Piquemal under the name « Skuldtech », with the support of Pr Jacques Marti and Pr Therese Commes-Maerten, and their academic laboratory (+)


Senior Management Didier Ritter: Chief Executive Officer, MSc in Molecular Biology and MBA, Founder of Acobiom, President of the boards of Kyomed and the Biomeridies Cluster, President and founder of (+)

Scientific Board


The scientific board of Acobiom is moving forward and will soon welcome Key Opinion Leader and personalities associated with Personalized Medicine, Translational Research and Omics BIG DATA.

News & press

Download our logo



Acobiom also welcomes each year trainees from French engineer’s schools and universities.

For job opportunities, please contact our company by email.